Sanofi Diabetes

Suliqua® SoloStar® 100/33

(insulin glargine (100units/mL) and lixisenatide)

(GB only)

Using your Suliqua® SoloStar® 100/33

Your Suliqua® SoloStar® 100/33 pen will help deliver the right dose of Suliqua for you. It is simple to use and you will quickly get to grips with how to use it and store it correctly.

Suliqua SoloStar 100/33 Prefilled Pen

How to use your Suliqua 100/33

Watch this video to learn how to use your Suliqua 100/33 pen. The animation takes you through how to prepare, use and store your Suliqua pen.

Patient Starting Guide

Starting on Suliqua?

The Patient Starting Guide provides information on how to store, prepare and use your new pen. It is a step by step guide that you can print off or follow on screen.


Your Suliqua 100/33 Passport

There may be occasions when it’s important for others to know which insulin you are taking.

This passport card is an easy way of ensuring that this information is available to you and others if needed. Download, print and fill in this Insulin passport. You can store it in your wallet or purse so it’s with you anywhere you go.

Suliqua 100/33 Passport
Toujeo SoloStar Handbook

Recycle your
used insulin pen

Sanofi is committed to environmental protection. That's why we're launching RePen, a pilot program that will recycle used insulin pens. It's easy to participate. Just drop off your empty pen within a collection envelope you can order online. Help us make a difference for the environment. Recycle your used insulin pen today.

Recycle now

Living well with Type 2 Diabetes

Understanding your condition is pivotal to living your best life with diabetes.

Download this booklet if you’d like to understand your diabetes better. It gives you clear information about type 2 diabetes, as well as what to be mindful of to ensure you keep yourself well and your diabetes well managed.

Ink Saving Version Original Version
Living well with type 2 diabetes

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at
By reporting side effects, you can help provide more information on the safety of this medicine.

MAT-GB-2102121 (v5.0)
Date of Preparation: March 2024